Voyager Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.6M | 15.3M | 13.4M | 5.2M | 6.5M | 6.3M | 24.6M | 29.6M |
| Cost of Goods Sold | 932K | 33.6M | 35.9M | 31.3M | 31.5M | 32.8M | 30.2M | 32.0M |
| Gross Profit | 1.7M | -18.2M | -22.5M | -26.1M | -25.1M | -26.5M | -5.6M | -2.4M |
| R&D Expenses | 24.6M | 36.0M | 35.9M | 31.3M | 31.5M | 35.6M | 30.2M | 34.5M |
| Operating Expenses | 31.9M | 11.7M | 8.1M | 10.5M | 9.6M | 11.8M | 8.2M | 12.7M |
| Operating Income | -30.3M | -29.9M | -30.6M | -36.6M | -34.7M | -38.3M | -13.8M | -15.0M |
| Other Income / Gains | 2.3M | 2.5M | 2.8M | 3.3M | 3.7M | 4.4M | 4.8M | 4.9M |
| Net Income | -27.9M | -27.4M | -27.9M | -33.4M | -31.0M | -34.5M | -9.0M | -10.1M |
| EPS (Diluted) | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 | -0.59 | -0.16 | -0.18 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.641 | -1.188 | -1.684 | -5.025 | -3.87 | -4.226 | -0.228 | -0.08 |
| General And Administrative Expenses | 8.3M | 8.2M | 8.1M | 10.5M | 9.6M | 9.0M | 8.2M | 10.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 8.3M | 8.2M | 8.1M | 10.5M | 9.6M | 9.0M | 8.2M | 10.2M |
| Other Expenses | -932K | -32.5M | -35.9M | -31.3M | -31.5M | -32.8M | -30.2M | -32.0M |
| Cost And Expenses | 32.9M | 45.3M | 44.0M | 41.8M | 41.2M | 44.6M | 38.4M | 44.6M |
| Interest Income | 1.9M | 2.1M | 2.4M | 2.8M | 3.3M | 4.0M | 4.6M | 4.9M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 932K | 1.0M | 932K | 1.1M | 1.0M | 1.0M | 1.1M | 1.4M |
| Ebitda | -27.0M | -26.4M | -26.9M | -32.3M | -30.0M | -32.9M | -7.9M | -11.1M |
| Ebitdaratio | -10.409 | -1.719 | -2.011 | -6.212 | -4.63 | -5.239 | -0.32 | -0.376 |
| Operating Income Ratio | -11.674 | -1.952 | -2.289 | -7.043 | -5.36 | -6.101 | -0.56 | -0.508 |
| Income Before Tax | -27.9M | -27.4M | -27.8M | -33.4M | -31.0M | -33.9M | -9.0M | -10.1M |
| Income Before Tax Ratio | -10.769 | -1.788 | -2.081 | -6.417 | -4.787 | -5.40 | -0.365 | -0.342 |
| Income Tax Expense | 14K | 9K | 83K | 15K | 37K | 584K | 43K | 24K |
| Net Income Ratio | -10.774 | -1.788 | -2.087 | -6.42 | -4.792 | -5.493 | -0.367 | -0.343 |
| Epsdiluted | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 | -0.59 | -0.16 | -0.18 |
| Weighted Average Shs Out | 59.5M | 58.7M | 58.8M | 58.7M | 58.3M | 58.0M | 57.9M | 57.7M |
| Weighted Average Shs Out Dil | 59.5M | 58.7M | 58.8M | 58.7M | 58.3M | 58.0M | 57.9M | 57.7M |